FDA's Evolving Regulation of Artificial Intelligence in Digital Health Products


The Situation: FDA has been grappling with regulation of rapidly advancing digital products, including artificial intelligence. While Congress and FDA have provided recent clarifications, regulatory questions remain. The Result: Both the 21st Century Cures Act and recent FDA activities provide important, but incomplete, insight regarding regulation of health products utilizing artificial intelligence. Looking Ahead: Digital health product manufacturers should recognize how recent regulatory changes may affect them, and that FDA is engaging industry to further refine its oversight approach.

Featured Posts
Posts à venir
Tenez-vous à jour...
Recent Posts
Archive
Search By Tags
Pas encore de mots-clés.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Social Icon

© 2017 - Clinnocare

N° SIRET: 829571017 00021